Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502155 | SCV000594956 | pathogenic | Maturity-onset diabetes of the young type 2 | 2015-08-20 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002438219 | SCV002605367 | likely pathogenic | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs1554335752 in MODY, yet. | |
Ambry Genetics | RCV002438219 | SCV002750077 | pathogenic | Maturity onset diabetes mellitus in young | 2018-08-07 | criteria provided, single submitter | clinical testing | The c.295delT pathogenic mutation, located in coding exon 3 of the GCK gene, results from a deletion of one nucleotide at nucleotide position 295, causing a translational frameshift with a predicted alternate stop codon (p.W99Gfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |